MedTrace Logo

Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients

NCT06935292 · Status: NOT_YET_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-04-20

No results posted yet for this study

Summary

The aim of this study is to compare the efficacy of oral melatonin versus nebulized dexmedetomidine in attenuating the hemodynamic response to direct laryngoscopy and endotracheal intubation in controlled hypertensive patients prepared for general anesthesia

Conditions

  • Tracheal Intubation Morbidity
  • Laryngoscopy
  • Hemodynamic Response

Interventions

DRUG

Dexmedetomidine

Nebulized Dexmedetomidine (1μg/kg)

DRUG

Melatonin

Oral Melatonin tablet (5mg)

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Aya GAE Ismaeil, MBBCH · Faculty of Medicine, Tanta University, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2026-04-30
Completion
2026-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06935292 on ClinicalTrials.gov